tinnitus objective measurement ai

BTA Awards £118k Research Grant for Development of Objective Measure of Tinnitus

SHEFFIELD, ENGLAND — The British Tinnitus Association (BTA) has announced that it is awarding a grant of £118,000 (~$161K USD) to a team from Macquarie University, Australia for a study that aims to develop a reliable objective measure of tinnitus. The three-year research project – led by Professor David McAlpine of Macquarie University, New South…

Read More
oto tinnitus app

Oto Announces the Launch of its First Product – a Digital Therapy Solution for Tinnitus

LONDON, UNITED KINGDOM – Oto today announces the launch of its new mobile app that allows people with tinnitus to access evidence-based therapy when they need it. Oto solves the problem of inaccessible and expensive therapy for the 1 in 8 people with tinnitus by bringing together on a simple digital platform all the therapies that research has…

Read More
american tinnitus association

American Tinnitus Association Receives $2.7 Million Legacy Gift

VIENNA, VIRGINIA — The American Tinnitus Association (ATA) today announced a $2.7 million legacy gift made possible by a long-time donor. “In a year of extraordinary turmoil and hardship, this bequest is humbling and received with deep gratitude. As a smaller nonprofit with a sizeable mission, this donation is transformational and will enable us to…

Read More
tinnitus twins research grant

British Tinnitus Association Awards £125k Grant for Research that Could Predict Who Will Develop Tinnitus

SHEFFIELD, ENGLAND — The British Tinnitus Association (BTA) has announced the first recipient of £125,000 (~167K $US) through the organization’s 2020/21 large research grant funding programme. The grant is going to King’s College London and the University of Nottingham for their study which aims to identify tinnitus biomarkers, using the health and genetics data of…

Read More
measuring tinnitus objectively

Researchers Develop New Technology to Objectively Measure Tinnitus

Researchers in Australia have developed a new technology to objectively measure tinnitus, according to a recently published in the journal PLOS ONE.  Dr Mehrnaz Shoushtarian from the Bionics Institute led the research, along with collaborators from Deakin University.  Chronic tinnitus affects around 6–20% of adults with approximately 20% of these experiencing it in a severe…

Read More
cbt tinnitus book

Beukes and Manchaiah Author New Book: Cognitive Behavioral Therapy for Tinnitus

BEAUMONT, TEXAS – The Lamar University Department of Speech and Hearing has announced the publication of Cognitive Behavioral Therapy for Tinnitus written in part by Eldre Beukes, lead author and post-doctoral researcher in the department and Vinaya Manchaiah, Jo Mayo Endowed Professor. Cognitive Behavioral Therapy for Tinnitus is the first book to provide comprehensive cognitive…

Read More
tinnitus worse covid-19

Study Finds 40% of Those Displaying COVID-19 Symptoms Experience Worsening of Tinnitus

CAMBRIDGE, UNITED KINGDOM — New research reveals that tinnitus, a common condition that causes the perception of noise in the ear and head, is being exacerbated by COVID-19 – as well as the measures helping to keep us safe. The study of 3,103 people with tinnitus was led by Anglia Ruskin University (ARU), with support…

Read More
lenire tinnitus treatment

Neuromod Closes €10.5 Million Series B Financing for Tinnitus Device; Eyes European and US Expansion

DUBLIN, IRELAND — Neuromod Devices Limited, the Irish medical device company specializing in the treatment of tinnitus, has announced that it has successfully raised €10.5 million (~$12.5M USD) in an oversubscribed Series B financing. The investment was led by majority investor Fountain Healthcare Partners, with participation from existing investors Moffett Investment Holdings and Medical Device…

Read More
tinnitus lenire

Neuromod Publishes Results of Large-Scale Tinnitus Clinical Trial with Lenire Device

DUBLIN, IRELAND – Neuromod Devices Limited (“Neuromod”), an Irish medical device company specializing in the treatment of chronic tinnitus, has published the results of the Company’s TENT A1 (Treatment Evaluation of Neuromodulation for Tinnitus) clinical trial in this week’s edition of Science Translational Medicine in a paper titled: ‘Bimodal neuromodulation combining sound and tongue stimulation…

Read More
tinnitus clinical trial otonomy

Otonomy Reports Positive Top-Line Results from Phase 1/2 Clinical Trial of OTO-313 for Tinnitus

SAN DIEGO, CALIFORNIA — Otonomy, Inc., a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, announced positive top-line results from the Phase 1/2 clinical trial of OTO-313 in patients with persistent tinnitus of at least moderate severity. The exploratory efficacy cohort of the trial included 31 evaluable patients randomized to a single…

Read More